StockOtters
StockOttersSupply Chain Map
Shanghai Henlius Biotech, Inc. logo

Shanghai Henlius Biotech, Inc.

2696.HK

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
744
Cost of Revenue
200
Gross Profit
544
Gross Margin
73.1%
Operating Income
122
Operating Margin
16.4%
Net Income
107
Net Margin
14.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
149
EBITDA Margin
20.0%

2023

12/31/2023

Revenue
701
Cost of Revenue
192
Gross Profit
509
Gross Margin
72.6%
Operating Income
82
Operating Margin
11.7%
Net Income
71
Net Margin
10.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
118
EBITDA Margin
16.9%

2022

12/31/2022

Revenue
418
Cost of Revenue
110
Gross Profit
308
Gross Margin
73.7%
Operating Income
-82
Operating Margin
-19.6%
Net Income
-90
Net Margin
-21.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-40
EBITDA Margin
-9.7%

2021

12/31/2021

Revenue
219
Cost of Revenue
68
Gross Profit
151
Gross Margin
68.9%
Operating Income
-86
Operating Margin
-39.5%
Net Income
-128
Net Margin
-58.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-87
EBITDA Margin
-39.9%

2020

12/31/2020

Revenue
76
Cost of Revenue
24
Gross Profit
53
Gross Margin
69.0%
Operating Income
-120
Operating Margin
-157.4%
Net Income
-129
Net Margin
-169.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-106
EBITDA Margin
-138.5%